Details for New Drug Application (NDA): 202759
✉ Email this page to a colleague
NDA 202759 describes GLIMEPIRIDE, which is a drug marketed by Accord Hlthcare, Actavis Labs Fl Inc, Aurobindo Pharma Ltd, Carlsbad, Chartwell Molecular, Dr Reddys Labs Ltd, Epic Pharma Llc, Hikma Pharms, Indoco Remedies, Micro Labs, Mylan, Norvium Bioscience, Prinston Inc, Ranbaxy, Ranbaxy Labs Ltd, Teva, and Watson Labs, and is included in seventeen NDAs. It is available from thirty-two suppliers. Additional details are available on the GLIMEPIRIDE profile page.
The generic ingredient in GLIMEPIRIDE is glimepiride. There are sixteen drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the glimepiride profile page.
The generic ingredient in GLIMEPIRIDE is glimepiride. There are sixteen drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the glimepiride profile page.
Summary for 202759
| Tradename: | GLIMEPIRIDE |
| Applicant: | Aurobindo Pharma Ltd |
| Ingredient: | glimepiride |
| Patents: | 0 |
Suppliers and Packaging for NDA: 202759
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| GLIMEPIRIDE | glimepiride | TABLET;ORAL | 202759 | ANDA | Rising Pharma Holdings, Inc. | 16571-773 | 16571-773-01 | 100 TABLET in 1 BOTTLE (16571-773-01) |
| GLIMEPIRIDE | glimepiride | TABLET;ORAL | 202759 | ANDA | Rising Pharma Holdings, Inc. | 16571-773 | 16571-773-50 | 500 TABLET in 1 BOTTLE (16571-773-50) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 1MG | ||||
| Approval Date: | Jun 29, 2012 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 2MG | ||||
| Approval Date: | Jun 29, 2012 | TE: | AB | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 4MG | ||||
| Approval Date: | Jun 29, 2012 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
